Electrode patch and tumor electric field treatment system

By adopting a multi-layer flexible structure electrode patch, the problems of insufficient flexibility of ceramic dielectric sheets and insufficient safety performance of flexible dielectric materials are solved, and a flexible and safe electrode patch is achieved, which improves the stability and safety performance of applying , extends the service life.

CN221964327UActive Publication Date: 2024-11-08JIANGSU HEALTHY LIFE INNOVATION MEDICAL TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202323491060.1
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-20
Publication Date
2024-11-08
Estimated Expiration
2033-12-20

AI Technical Summary

Technical Problem

The existing electrode patches are not flexible and have too large self-weight due to the lack of flexibility of ceramic dielectric sheets, which leads to unstable patches and affects the treatment effect. The flexible dielectric materials have serious heat generation and insufficient safety performance.

Method used

Electrode patches with multi-layer flexible structures include flexible circuit boards, conductive layers, polymer dielectric layers, alloy layers and biosafety protective layers. The area of ​​the polymer dielectric layer is greater than the area of ​​the conductive layer, and the edge of the alloy layer is located at the dielectric layer. Within the boundary, the biosafety protective layer is made of medical stainless steel or titanium, and the adhesive layer penetrates through the holes, and the electrode unit formed has good capacitive coupling and safety protection functions.

Benefits of technology

A flexible and safe electrode patch is achieved, avoiding non-capacitive coupling between the treatment electric field and the skin and edge heat concentration, improving patch stability and safety performance, reducing the weight of the electrode patch, and extending the service cycle.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221964327U_ABST
    Figure CN221964327U_ABST
Patent Text Reader

Abstract

The utility model provides an electrode patch and a tumor electric field treatment system, the electrode patch comprises a transducer array with a plurality of electrode units, each electrode unit comprises a flexible circuit board and a flexible composite layer, and the flexible circuit board is provided with a flexible substrate and a conductive layer arranged on the flexible substrate; the flexible composite layer comprises a macromolecule dielectric layer covering the conductive layer, an alloy layer arranged on the macromolecule dielectric layer and a biological safety protection layer arranged on the alloy layer, wherein the area of the macromolecule dielectric layer is larger than that of the conductive layer. The electrode unit of the electrode patch is of a multi-layer flexible structure, the area of the macromolecule dielectric material layer is larger than that of the conducting layer, the edge of the conducting layer can be completely covered, non-capacitance coupling between a treatment electric field and the skin of the body surface of a patient is avoided, and the treatment effect is improved. And the phenomenon that the edge heat is excessively concentrated due to the coincidence of the edge of the conductive layer and the edge of the polymer dielectric layer is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to an electrode patch and a tumor electric field treatment system. Background Art

[0002] Medium frequency alternating electric field therapy has been proven to be an effective method for tumor treatment. The tumor electric field therapy system usually includes an electric field generator, an adapter and multiple pairs of electrode patches. The electric field generator device generates an alternating electric signal and transmits the alternating electric signal to the electrode patch through the adapter. The electrode patch is applied in pairs on the surfaces of the opposite sides of the patient's skin. The electrode patch is provided with a transducer array. The two transducer arrays of a pair of electrode patches are capacitively coupled with the applied skin and form a therapeutic electric field between the two transducers to interfere with the mitotic process of tumor cells. The transducer array in the existing electrode patch usually uses ceramic material as a dielectric sheet, and the ceramic dielectric sheet that meets the requirements of electric field application has a certain thickness and a certain rigidity. When the existing transducer array is applied to the patient's body surface, due to the insufficient flexibility of the ceramic dielectric sheet, it cannot be well attached to the patient's body surface, which affects the stability of the transducer array; on the other hand, the self-weight of the ceramic dielectric sheet array will also affect the patient's feeling of application. Flexible dielectric materials are also currently used, but flexible dielectric materials can cause problems such as severe heat generation and insufficient safety performance.

[0003] Therefore, there is a need to improve the existing electrode patches and tumor electric field therapy systems. Utility Model Content

[0004] The present application provides an electrode patch and a tumor electric field treatment system that is more flexible and safer.

[0005] Specifically, the present application is implemented through the following technical solutions: an electrode patch for a tumor electric field therapy system, comprising a transducer array having a plurality of electrode units, wherein the electrode unit comprises a flexible circuit board and a composite layer, wherein the flexible circuit board is provided with a flexible substrate and a conductive layer arranged on the flexible substrate, wherein the flexible composite layer comprises a polymer dielectric layer covering the conductive layer, an alloy layer arranged on the polymer dielectric layer, and a biosafety protection layer arranged on the alloy layer, wherein the area of ​​the polymer dielectric layer is greater than the area of ​​the conductive layer.

[0006] According to an embodiment of the present invention, the area of ​​the polymer dielectric layer is 1.1 to 1.3 times the area of ​​the conductive layer.

[0007] According to an embodiment of the present invention, the edge of the alloy layer is located within the boundary of the polymer dielectric layer.

[0008] According to an embodiment of the present invention, the area of ​​the alloy layer accounts for 90% to 100% of the area of ​​the conductive layer.

[0009] According to an embodiment of the present invention, the thickness ratio of the alloy layer to the polymer dielectric layer is set at 1:1000 to 100:1000.

[0010] According to an embodiment of the present invention, the area of ​​the biosafety protection layer is not less than the area of ​​the flexible substrate, and the material of the biosafety protection layer is medical stainless steel or titanium.

[0011] According to an embodiment of the utility model, the flexible composite layer further comprises an adhesive layer for bonding the biosafety protection layer to the alloy layer, and the adhesive layer is provided with a plurality of through holes.

[0012] According to an embodiment of the present invention, the area of ​​the bonding layer accounts for 30% to 90% of the area of ​​the alloy layer.

[0013] According to an embodiment of the present invention, the layers of the electrode unit are arranged in descending order according to area size: biosafety protection layer, flexible substrate, polymer dielectric layer, conductive layer, alloy layer, and adhesive layer.

[0014] The present application also provides a tumor electric field therapy system, including an electric field generator that generates an alternating electric signal, an adapter that is electrically connected to the electric field generator and transmits the alternating electric signal, and a plurality of electrode patches that are electrically connected to the adapter and apply the alternating electric signal, wherein the electrode patches are the aforementioned electrode patches.

[0015] The electrode unit of the electrode patch of the present application is a multi-layer flexible structure, and the area of ​​its polymer dielectric material layer is larger than that of the conductive layer, which can completely cover the edge of the conductive layer, thereby avoiding non-capacitive coupling between the therapeutic electric field and the patient's skin, and avoiding the phenomenon of excessive edge heat concentration caused by the overlap of the edge of the conductive layer and the edge of the polymer dielectric layer.

[0016] It should be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present application. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 Schematic diagram of the tumor electric field treatment system of the present application.

[0018] Figure 2 For this application Figure 1 A three-dimensional view of an electrode patch according to an embodiment is shown.

[0019] Figure 3 for Figure 2 A plan view of the electrode patch shown in FIG. 1 with the backing removed.

[0020] Figure 4 For along Figure 3 Cross-section view of line AA in .

[0021] Description of reference numerals:

[0022] Tumor electric field therapy system 100, electric field generator 1, electrode patch 2, adapter 3, transducer array 25, backing 20, connecting part 21, electrode unit 22, wiring part 23, flexible circuit board 221, flexible substrate 2211, conductive layer 2212, flexible composite layer 222, flexible composite layer 222, polymer dielectric layer 2221, alloy layer 2222, biosafety protection layer 2223, adhesive layer 2224, through hole 110. DETAILED DESCRIPTION

[0023] Here, exemplary embodiments will be described in detail, examples of which are shown in the accompanying drawings. When the following description refers to the drawings, unless otherwise indicated, the same numbers in different drawings represent the same or similar elements. The embodiments described in the following exemplary embodiments do not represent all embodiments consistent with the present application. Instead, they are only examples of devices, systems, equipment and methods consistent with some aspects of the present application.

[0024] refer to Figure 1 As shown, the tumor electric field treatment system 100 of the present application includes an electric field generator 1, several pairs of electrode patches 2 and an adapter 3. The electrode patch 2 can be applied to the body surface of the patient's tumor site. The electric field generator 1 generates an alternating electric signal that meets the requirements for treatment and transmits it to the electrode patch 2 through the adapter 3, so that each pair of electrode patches 2 generates an alternating electric field through capacitive coupling with the body surface, thereby performing electric field treatment on the tumor site.

[0025] The electrode patch 2 in this application adopts a flexible structure, refer to Figure 2 and Figure 3 As shown in FIG. 1 , as a specific embodiment of the electrode patch 2, it includes a transducer array 25 and a backing 20. The transducer array 25 is arranged roughly in a daisy shape and is pasted on the backing 20. The transducer array 25 includes a connecting portion 21 located at the center, a plurality of strip-shaped electrode units 22 extending radially from the connecting portion 21, and a wiring portion 23 extending outward from the connecting portion 21. The electrode patch 2 is electrically connected to the adapter 3 through the wiring portion 23 to receive the alternating electric signal from the electric field generator 1.

[0026] refer to Figure 4As shown, the electrode unit 22 of the transducer array 25 is a multi-layer structure, which generally includes a flexible circuit board 221 and a flexible composite layer 222 covering the flexible circuit board 221, wherein the flexible circuit board 221 further includes a flexible substrate 2211 and a conductive layer 2212 arranged on the front of the flexible substrate 2211, and the conductive layer 2212 is a conductive sheet exposed on the front of the flexible substrate 2211, and the conductive sheet can be made of a metal conductive material such as copper foil, or a polymer conductive material such as polypyrrole, polyphenylene sulfide, etc. The connecting portion 21, the wiring portion 23 and each flexible circuit board 221 are different parts of the same flexible circuit board (not numbered), and the flexible circuit board (not numbered) is also arranged with a plurality of conductive traces (not shown) respectively connecting the wiring portion 23 and each conductive layer 2212, so as to transmit the alternating electric signal from the electric field generator 1 to each conductive layer 2212.

[0027] The flexible composite layer 222 is arranged corresponding to the conductive layer 2212 and covers the front of the conductive layer 2212, providing capacitive coupling and safety protection functions for the conductive layer 2212. The flexible composite layer 222 includes a polymer dielectric layer 2221 covering the conductive layer 2212, an alloy layer 2222 arranged on the polymer dielectric layer 2221, and a biosafety protection layer 2223 arranged on the alloy layer 2222. The polymer dielectric layer 2221 is tightly attached to the conductive layer 2212 to transfer the alternating electrical signal received by the conductive layer 2212 to the patient's body surface in a capacitive coupling manner to form a therapeutic alternating electric field. The biosafety protection layer 2223 can prevent the non-capacitive coupling caused by the subject's body fluids penetrating into the polymer dielectric layer 2221 or the flexible circuit board 221, thereby improving the safety performance during electric field therapy.

[0028] Since the polymer dielectric layer 2221 is highly lightweight while meeting the dielectric properties required for electric field therapy, the biosafety protection layer 2223 is directly combined with the polymer dielectric layer 2221 and cannot form a tight connection with it without affecting the dielectric properties of the polymer dielectric layer 2221, which causes serious loss of the alternating electric signal when flowing between the two, resulting in serious heating and affecting the effective application of the therapeutic electric field. Therefore, an alloy layer 2222 is set between the polymer dielectric layer 2221 and the biosafety protection layer 2223. The alloy layer 2222 can be attached to the polymer dielectric layer 2221 through a deposition process and form a close match with it, and due to the good conductivity of the alloy layer 2222 itself, it can be made very thin without affecting the overall lightweight of the electrode unit 22 due to the addition of the alloy layer 2222. The biosafety protection layer 2223 is in contact with the alloy layer 2222, which not only ensures the circulation of the alternating electric signal but also reduces the loss. An adhesive layer 2224 may be provided between the alloy layer 2222 and the biosafety protection layer 2223. The adhesive layer 2224 may bond and fix the biosafety protection layer 2223 to the alloy layer 2222, so as to enhance the tightness and conductivity of the connection between the alloy layer 2222 and the biosafety protection layer 2223, and prevent the biosafety protection layer 2223 from shifting or falling off relative to the alloy layer 2222. The polymer dielectric layer 2221 and the biosafety protection layer 2223 are tightly combined through the alloy layer 2222 and the adhesive layer 2224, so as to avoid the electric field loss and the increase of the loss due to the non-tight combination.

[0029] Continue to refer Figure 4 As shown, the above-mentioned structure of each layer of the electrode unit 22 is introduced below.

[0030] The flexible circuit board 221 has the characteristics of light weight, thin thickness, bendability, high flexibility, etc. The material of the flexible substrate 2211 of the flexible circuit board 221 is polyimide or polyester film material, with a thickness of 100-300 μm. The conductive layer 2212 protrudes from the front of the flexible substrate 2211 and has a thickness of 10-50 μm. The area of ​​the conductive layer 2212 is smaller than the area of ​​the flexible substrate 2211, and the shape, size and specific position of the conductive layer 2212 on the surface of the flexible substrate 2211 are not limited.

[0031] The polymer dielectric layer 2221 is made of a polymer material with non-fixed crystal orientation, high flexibility and high toughness, and has the characteristics of high dielectric constant and low dielectric loss. The dielectric constant of the polymer dielectric layer 2221 is not less than 20, and the dielectric strength is not less than 40V / μm to avoid breakdown under normal applied voltage. The material forming the polymer dielectric layer 2221 can be a ternary copolymer based on a relaxor ferroelectric, such as a vinylidene fluoride-trifluoroethylene-chlorotrifluoroethylene copolymer or a vinylidene fluoride-trifluoroethylene-chlorofluoroethylene copolymer, or a piperazine biuret Biuret copolymer polyamide film. The polymer dielectric layer 2221 can be formed on the surface of the conductive layer 2212 by vapor deposition such as evaporation, sputtering or ion plating, or can be formed on the surface of the conductive layer 2212 by printing, spraying or casting. In the present embodiment, the polymer dielectric layer 2221 is formed on the surface of the conductive layer 2212 by vacuum sputtering. The thickness of the polymer dielectric layer 2221 is 3-10 μm to ensure that it is not broken down under the alternating voltage of the electric field therapy. Preferably, the thickness of the polymer dielectric layer 2221 is 5 μm, which can meet the voltage test of at least 200V without breakdown. The area of ​​the polymer dielectric layer 2221 is set to be larger than the area of ​​the conductive layer 2212 to completely cover the edge of the conductive layer 2212, avoid non-capacitive coupling between the therapeutic electric field and the patient's skin, and avoid the edge of the conductive layer 2212 and the edge of the polymer dielectric layer 2221 overlapping to cause the edge heat to be too concentrated. Preferably, the area of ​​the polymer dielectric layer 2221 is approximately 1.1 to 1.3 times the area of ​​the conductive layer 2212. In addition, the area of ​​the polymer dielectric layer 2221 is not larger than the area of ​​the flexible substrate 2211.

[0032] The material of the alloy layer 2222 can be one or more of zinc-aluminum alloy, zinc-copper alloy, silver-titanium alloy, graphite, etc. The alloy layer 2222 can be deposited on the polymer dielectric layer 2221 using a vapor deposition method to form a close bond with the polymer dielectric layer 2221. The alloy layer 2222 can also use a vacuum sputtering process similar to the formation of the polymer dielectric layer 2221, and of course other deposition processes can also be used. The area of ​​the alloy layer 2222 is smaller than the area of ​​the polymer dielectric layer 2221, and the edge of the alloy layer 2222 is located within the boundary of the polymer dielectric layer 2221 to prevent metal ions at the edge of the alloy layer 2222 from leaking to the conductive layer 2212. The area of ​​the alloy layer 2222 is not larger than the area of ​​the conductive layer 2212. Preferably, the area of ​​the alloy layer 2222 accounts for approximately 90% to 100% of the area of ​​the conductive layer 2212. The thickness of the alloy layer 2222 is inversely proportional to its loss, that is, the thicker the alloy layer 2222, the lower the loss; the thickness of the alloy layer 2222 is inversely proportional to the bonding tightness of the polymer dielectric layer 2221, that is, the thicker the alloy layer 2222, the lower the bonding tightness. In order to obtain an electrode unit with lower loss and stronger tightness, the thickness ratio of the alloy layer 2222 to the polymer dielectric layer 2221 is set in the range of 1:1000 to 100:1000. In this embodiment, the thickness of the alloy layer 2222 is 3-100nm.

[0033] The adhesive layer 2224 is directly pressed and arranged on the surface of the alloy layer 2222. The adhesive layer 2224 can be provided with a plurality of regular or irregular through holes 110 that connect the alloy layer 2222 and the biosafety protection layer 2223, and the through holes 110 can conduct the electric field voltage on the alloy layer 2222. The thickness of the adhesive layer 2224 is 10-100 μm. The area of ​​the adhesive layer 2224 is smaller than that of the alloy layer 2222, and accounts for about 30%-90% of the area of ​​the alloy layer 2222.

[0034] The biosafety protection layer 2223 serves as a water-blocking protective layer with excellent conductivity and reliable biocompatibility. It can directly contact the patient's body surface without causing adverse reactions to the patient's skin. Medical stainless steel or titanium is preferred. The thickness of the biosafety protection layer 2223 is 100-200μm. The area of ​​the biosafety protection layer 2223 is not less than the area of ​​the flexible substrate 2211. The biosafety protection layer 2223 located at the outermost side of the electrode unit 22 can not only provide durable protection for the combination of the flexible circuit board 221 and the flexible composite layer 222, but also provide a lateral heat dissipation channel to avoid the heat generated by the alternating electric field applied by the electrode unit 22 from diffusing to the body surface or the body heat from diffusing to the electrode unit 22, causing discomfort.

[0035] In summary, the thickness of each layer structure of the electrode unit 22 is summarized as follows: the thickness of the flexible substrate 2211 is 100-300 μm, the thickness of the conductive layer 2212 is 10-50 μm, the thickness of the polymer dielectric layer 2221 is 3-10 μm, the thickness of the alloy layer 2222 is 3-100 nm, the thickness of the adhesive layer 2224 is 10-100 μm, and the thickness of the biosafety protection layer 2223 is 100-200 μm. The area relationship of each layer structure is as follows: biosafety protection layer 2223 ≥ flexible substrate 2211 ≥ polymer dielectric layer 2221 > conductive layer 2212 ≥ alloy layer 2222 > adhesive layer 2224.

[0036] Figure 4 The diagram shown in the figure is an enlarged schematic diagram of each layer being smoothly spread out, and the layers are not separated and not connected. For example, the polymer dielectric layer 2221 completely covers the conductive layer 2212, and its edge should be located on the flexible substrate 2211; the biosafety protection layer 2223 has the largest area, and its edge should overlap with the edge of the flexible substrate 2211 or pass over the edge of the flexible substrate 2211 and be folded to the back of the flexible substrate 2211.

[0037] In other embodiments, the electrode patch 2 includes only the transducer array 25 without the backing 20, such as by applying a biocompatible material with conductive adhesion on the surface of the biosafety protection layer 2223 to directly attach the transducer array 25 to the body surface, or by pressing the transducer array 25 to the body surface through wearable clothing (not shown).

[0038] The overall thickness of the electrode unit 22 of the electrode patch 2 does not exceed 660 μm, and each layer structure has the characteristics of low thickness and high flexibility. The overall structure has high stability and good biosafety, which can greatly reduce the weight of the electrode patch 2, improve heat dissipation performance, maintain the application of effective therapeutic electric field, and extend the service life of the electrode patch 2.

[0039] The above is only a preferred implementation mode of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present application should be included in the scope of protection of the present application.

Claims

1. An electrode patch for use in a tumor electric field treatment system, characterized in that: The invention comprises a transducer array having a plurality of electrode units, wherein the electrode units comprise a flexible circuit board and a flexible composite layer, wherein the flexible circuit board is provided with a flexible substrate and a conductive layer provided on the flexible substrate; the flexible composite layer comprises a polymer dielectric layer covering the conductive layer, an alloy layer provided on the polymer dielectric layer and a biosafety protection layer provided on the alloy layer, wherein the area of ​​the polymer dielectric layer is greater than the area of ​​the conductive layer.

2. The electrode patch according to claim 1, characterized in that: The area of ​​the polymer dielectric layer is 1.1 to 1.3 times the area of ​​the conductive layer.

3. The electrode patch according to claim 1, characterized in that: The edge of the alloy layer is located within the boundary of the polymer dielectric layer.

4. The electrode patch according to claim 3, characterized in that: The area of ​​the alloy layer accounts for 90% to 100% of the area of ​​the conductive layer.

5. The electrode patch according to claim 3, characterized in that: The thickness ratio of the alloy layer to the polymer dielectric layer is set at 1:1000 to 100:1000.

6. The electrode patch according to claim 1, characterized in that: The area of ​​the biosafety protection layer is not less than the area of ​​the flexible substrate, and the material of the biosafety protection layer is medical stainless steel or titanium.

7. The electrode patch according to claim 1, characterized in that: The flexible composite layer also includes an adhesive layer for bonding the biosafety protection layer to the alloy layer, and the adhesive layer is provided with a plurality of through holes.

8. The electrode patch according to claim 7, characterized in that: The area of ​​the bonding layer accounts for 30% to 90% of the area of ​​the alloy layer.

9. The electrode patch according to claim 7, characterized in that: The layers of the electrode unit are arranged in descending order according to area size: a biosafety protection layer, a flexible substrate, a polymer dielectric layer, a conductive layer, an alloy layer and an adhesive layer.

10. A tumor electric field treatment system, characterized in that: It comprises an electric field generator that generates an alternating electric signal, an adapter that is electrically connected to the electric field generator and transmits the alternating electric signal, and a plurality of electrode patches that are electrically connected to the adapter and apply the alternating electric signal, wherein the electrode patch is the electrode patch according to any one of claims 1 to 9.

Citation Information

Cited By

  • Tumor electric field treatment system

    CN119701207A